Microbiota-derived isovalerate ameliorates sex-specific gut barrier dysfunction in malnutrition.
Summary
Using specific pathogen-free and germ-free mice, targeted metabolomics, and human-derived colonoid monolayers, the study identified branched-chain fatty acids, particularly isovalerate, as microbiota-derived regulators of intestinal barrier integrity. Isovalerate enemas and leucine gavage restored claudin-8 localization and reduced permeability in malnourished male mice, providing a mechanistic link between malnutrition, dysbiosis, gut leak, and sepsis risk.
Key Findings
- Malnutrition increased colonic permeability and bacterial translocation in male specific pathogen-free mice but not in female mice.
- Branched-chain fatty acids were depleted in malnourished mice, and isovalerate improved epithelial barrier function in human-derived colonoid monolayers.
- Isovalerate enemas or leucine gavage restored claudin-8 localization and reduced colonic permeability in malnourished male mice.
Clinical Implications
The findings support future testing of microbiota-directed nutritional strategies, such as leucine supplementation or targeted delivery of branched-chain fatty acids, in malnourished patients at risk of bacterial translocation and sepsis. Clinical translation requires dose, safety, sex-specific effects, and microbiome-dependent responses to be established.
Why It Matters
This study identifies a specific microbial metabolite and its dietary precursor as experimentally tractable interventions for malnutrition-associated barrier failure, a clinically important pathway that can promote bacterial translocation and sepsis. The use of germ-free animals, human colonoids, and in vivo rescue strengthens causal interpretation.
Limitations
- The principal efficacy experiments were conducted in mice, limiting direct extrapolation to human malnutrition and sepsis.
- The observed effects were sex-specific in vivo, and the determinants of this sex difference require further investigation.
Future Directions
Future studies should evaluate leucine or isovalerate-based interventions in clinically relevant malnutrition models, define optimal delivery and dosing, assess antimicrobial and metabolic safety, and determine whether baseline microbiome composition predicts response. Early-phase human studies should include gut permeability, bacterial translocation, and infection outcomes.
Study Information
- Study Type
- Basic/mechanistic research
- Research Domain
- Pathophysiology/Prevention
- Evidence Level
- IV - Mechanistic preclinical evidence supported by multiple experimental systems, without direct clinical outcome validation.
- Study Design